Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. (ELVN) Insider Trading
Directors, officers and holders of more than 10% of ELVN report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 329 transactions on file: 0 with code P, 25 with code S and 25 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | M Exercise | 6,018 | $14.85 | $89,367 |
| Oct 19, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 5,000 | $38.47 | $192,342 |
| Oct 19, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 6,018 | $38.48 | $231,546 |
| Oct 19, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | $2.48 | $12,400 |
| Oct 19, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | M Exercise | 6,018 | Not measured | Not measured |
| Oct 19, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | Not measured | Not measured |
| Oct 14, 2026 | BALL KRISTINE M | Director | A Award | 23,394 | Not measured | Not measured |
| Oct 1, 2026 | Garland J. Scott | Director | S Sale | 13,000 | $46.67 | $606,719 |
| Oct 1, 2026 | Garland J. Scott | Director | M Exercise | 13,000 | $15.47 | $201,110 |
| Oct 1, 2026 | Garland J. Scott | Director | M Exercise | 13,000 | Not measured | Not measured |
| Sep 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 1,844 | $50.71 | $93,507 |
| Sep 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 2,916 | $50.03 | $145,891 |
| Sep 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 289 | $51.49 | $14,881 |
| Sep 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 2,194 | $50.72 | $111,270 |
| Sep 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | M Exercise | 3,982 | $14.85 | $59,133 |
| Sep 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 3,535 | $50.03 | $176,851 |
| Sep 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | M Exercise | 3,982 | Not measured | Not measured |
| Sep 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | Not measured | Not measured |
| Sep 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 240 | $51.48 | $12,356 |
| Sep 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | $2.48 | $12,400 |
| Aug 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 1,100 | $59.35 | $65,281 |
| Aug 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | Not measured | Not measured |
| Aug 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 3,900 | $58.37 | $227,650 |
| Aug 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 1,388 | $59.35 | $82,383 |
| Aug 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | $2.48 | $12,400 |
| Aug 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 4,630 | $58.35 | $270,168 |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 23,364 | $14.85 | $346,955 |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 87,373 | Not measured | Not measured |
| Aug 4, 2026 | Derynck Mika K | Director | S Sale | 158,795 | $60.21 | $9,561,587 |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 87,373 | $2.48 | $216,685 |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 27,567 | Not measured | Not measured |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 23,364 | Not measured | Not measured |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 20,491 | Not measured | Not measured |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 20,491 | $22.47 | $460,433 |
| Aug 4, 2026 | Derynck Mika K | Director | M Exercise | 27,567 | $25.28 | $696,894 |
| Jul 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | M Exercise | 1,072 | Not measured | Not measured |
| Jul 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 369 | $51.48 | $18,997 |
| Jul 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 2,638 | $53.38 | $140,823 |
| Jul 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 63 | $53.92 | $3,397 |
| Jul 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | Not measured | Not measured |
| Jul 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 2,063 | $52.39 | $108,085 |
| Jul 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 459 | $51.55 | $23,660 |
| Jul 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 231 | $50.05 | $11,563 |
| Jul 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | M Exercise | 1,072 | $2.48 | $2,659 |
| Jul 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M Exercise | 5,000 | $2.48 | $12,400 |
| Jul 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S Sale | 2,184 | $53.42 | $116,669 |
| Jul 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 324 | $49.97 | $16,191 |
| Jul 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 123 | $53.87 | $6,626 |
| Jul 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | S Sale | 2,564 | $52.32 | $134,143 |
| Jul 6, 2026 | Kunkel Lori Anne | Director | S Sale | 4,111 | $49.98 | $205,482 |
The full Form 4 history is on the ELVN company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.